Antigen-specific responses accelerate bacterial clearance in the bladder

Journal of Immunology

Volumn 176, Issue 5, 2006, Pages 3080-3086

  Thumbikat, Praveen ^a   Waltenbaugh, Carl ^a   Schaeffer, Anthony J ^a   Klumpp, David J ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Department of Urology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; OVALBUMIN;

ACCELERATION; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; CELL PROLIFERATION; CONTROLLED STUDY; CYSTITIS; FEMALE; IMMUNE RESPONSE; IN VITRO STUDY; INFECTION SENSITIVITY; LEUKOCYTE; MORBIDITY; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECURRENT INFECTION; REINFECTION; SPLEEN CELL; T LYMPHOCYTE; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

EID: 33644509820     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.5.3080     Document Type: Article

References (34)

1. Schappert, S. M. 1999. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1997. Vital. Health Stat. 13: i-iv, 1-39.
2. Rosenberg, M. 1999. Pharmacoeconomics of treating uncomplicated urinary tract infections. Int. J. Antimicrob. Agents 11: 247-251.
3. Foxman, B., and P. Brown. 2003. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect. Dis. Clin. North Am. 17: 227-241.
4. Thomas, W. E., E. Trintchina, M. Forero, V. Vogel, and E. V. Sokurenko. 2002. Bacterial adhesion to target cells enhanced by shear force. Cell 109: 913-923.
5. 2+ oscillations in renal epithelial cells. Nature 405: 694-697.
6. Flatau, G., E. Lemichez, M. Gauthier, P. Chardin, S. Paris, C. Fiorentini, and P. Boquet. 1997. Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature 387: 729-733.
7. Elwell, C., K. Chao, K. Patel, and L. Dreyfus. 2001. Escherichia coli CdtB mediates cytolethal distending toxin cell cycle arrest. Infect. Immun. 69: 3418-3422.
8. Johnson, J. R., T. T. O'Bryan, D. A. Low, G. Ling, P. Delavari, C. Fasching, T. A. Russo, U. Carlino, and A. L. Stell. 2000. Evidence of commonality between canine and human extraintestinal pathogenic Escherichia coli strains that express papG allele III. Infect. Immun. 68: 3327-3336.
9. Mulvey, M. A., J. D. Schilling, J. J. Martinez, and S. J. Hultgren. 2000. Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. Proc. Natl. Acad. Sci. USA 97: 8829-8835.
10. Backhed, F., L. Meijer, S. Normark, and A. Richter-Dahlfors. 2002. TLR4-dependent recognition of lipopolysaccharide by epithelial cells requires sCD14. Cell. Microbiol. 4: 493-501.
11. Schilling, J. D., S. M. Martin, D. A. Hunstad, K. P. Patel, M. A. Mulvey, S. S. Justice, R. G. Lorenz, and S. J. Hultgren. 2003. CD14- and Toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli. Infect. Immun. 71: 1470-1480.
12. Mulvey, M. A., J. D. Schilling, and S. J. Hultgren. 2001. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect. Immun. 69: 4572-4579.
13. Martinez, J. J., M. A. Mulvey, J. D. Schilling, J. S. Pinkner, and S. J. Hultgren. 2000. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J. 19: 2803-2812.
14. Engel, J. D., and A. J. Schaeffer. 1998. Evaluation of and antimicrobial therapy for recurrent urinary tract infections in women. Urol. Clin. North Am. 25: 685-701, x.
15. Hopkins, W. J., L. J. James, E. Balish, and D. T. Uehling. 1993. Congenital immunodeficiencies in mice increase susceptibility to urinary tract infection. J. Urol. 149: 922-925.
16. Langermann, S., S. Palaszynski, M. Barnhart, O. Auguste, J. S. Pinkner, J. Burlein, P. Barren, S. Koenig, S. Leath, C. H. Jones, and S. J. Hultgren. 1997. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science 276: 607-611.
17. Roberts, J. A., M. B. Kaack, O. Baskin, M. R. Chapman, D. A. Hunstad, J. S. Pinkner, and S. J. Hultgren. 2004. Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein. J. Urol. 171: 1682-1685.
18. Duguid, J. P., and D. C. Old. 1980. Adhesive properties of enterobacteriaceae. In Bacterial Adherence. E. H. Beachey, ed. Chapman and Hall, London, pp. 185-217.
19. Gaffney, R. A., M. F. Venegas, C. Kanerva, E. L. Navas, B. E. Anderson, J. L. Duncan, and A. J. Schaeffer. 1995. Effect of vaginal fluid on adherence of type 1 piliated Escherichia coli to epithelial cells. J. Infect. Dis. 172: 1528-1535.
20. Hultgren, S. J., W. R. Schwan, A. J. Schaeffer, and J. L. Duncan. 1986. Regulation of production of type 1 pili among urinary tract isolates of Escherichia coli. Infect. Immun. 54: 613-620.
21. Iqbal, N., J. R. Oliver, F. H. Wagner, A. S. Lazenby, C. O. Elson, and C. T. Weaver. 2002. T helper 1 and T helper 2 cells are pathogenic in an antigen-specific model of colitis. J. Exp. Med. 195: 71-84.
22. Tanzola, M. B., M. Robbie-Ryan, C. A. Gutekunst, and M. A. Brown. 2003. Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course. J. Immunol. 171: 4385-4391.
23. Hopkins, W. J., J. A. Hall, B. P. Conway, and D. T. Uehling. 1995. Induction of urinary tract infection by intraurethral inoculation with Escherichia coli: refining the murine model. J. Infect. Dis. 171: 462-465.
24. Foxman, B., R. Barlow, H. D'Arcy, B. Gillespie, and J. D. Sobel. 2000. Urinary tract infection: self-reported incidence and associated costs. Ann. Epidemiol. 10: 509-515.
25. Foxman, B., B. Gillespie, J. Koopman, L. Zhang, K. Palin, P. Tallman, J. V. Marsh, S. Spear, J. D. Sobel, M. J. Marty, and C. F. Marrs. 2000. Risk factors for second urinary tract infection among college women. Am. J. Epidemiol. 151: 1194-1205.
26. Hopkins, W. J., A. Gendron-Fitzpatrick, E. Balish, and D. T. Uehling. 1998. Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains. Infect. Immun. 66: 2798-2802.
27. Agace, W. W., S. R. Hedges, M. Ceska, and C. Svanborg. 1993. Interleukin-8 and the neutrophil response to mucosal Gram-negative infection. J. Clin. Invest. 92: 780-785.
28. Agace, W., S. Hedges, U. Andersson, J. Andersson, M. Ceska, and C. Svanborg. 1993. Selective cytokine production by epithelial cells following exposure to Escherichia coli. Infect. Immun. 61: 602-609.
29. Godaly, G., A. E. Proudfoot, R. E. Offord, C. Svanborg, and W. W. Agace. 1997. Role of epithelial interleukin-8 (IL-8) and neutrophil 1L-8 receptor A in Escherichia coli-induced transuroepithelial neutrophil migration. Infect. Immun. 65: 3451-3456.
30. Ko, Y. C., N. Mukaida, S. Ishiyama, A. Tokue, T. Kawai, K. Matsushima, and T. Kasahara. 1993. Elevated interleukin-8 levels in the urine of patients with urinary tract infections. Infect. Immun. 61: 1307-1314.
31. Grischke, E. M., and H. Ruttgers. 1987. Treatment of bacterial infections of the female urinary tract by immunization of the patients. Urol. Int. 42: 338-341.
32. Eden, C. S., L. A. Hanson, U. Jodal, U. Lindberg, and A. S. Akerlund. 1976. Variable adherence to normal human urinary-tract epithelial cells of Escherichia coli strains associated with various forms of urinary-tract infection. Lancet 1: 490-492.
33. Svanborg-Eden, C., and A. M. Svennerholm. 1978. Secretory immunoglobulin A and G antibodies prevent adhesion of Escherichia coli to human urinary tract epithelial cells. Infect. Immun. 22: 790-797.
34. Trinchieri, A., L. Braceschi, D. Tiranti, S. Dell'Acqua, A. Mandressi, and E. Pisani. 1990. Secretory immunoglobulin A and inhibitory activity of bacterial adherence to epithelial cells in urine from patients with urinary tract infections. Urol. Res. 18: 305-308.